Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6KAY

X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by soaking

6KAY の概要
エントリーDOI10.2210/pdb6kay/pdb
分子名称Peroxisome proliferator-activated receptor alpha, 2-[(4-{2-[(4-cyclohexylbutyl)(cyclohexylcarbamoyl)amino]ethyl}phenyl)sulfanyl]-2-methylpropanoic acid, GLYCEROL, ... (4 entities in total)
機能のキーワードnuclear receptor, protein-ligand complex, ppar, transcription
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数1
化学式量合計31450.90
構造登録者
Kamata, S.,Suda, K.,Saito, K.,Oyama, T.,Ishii, I. (登録日: 2019-06-24, 公開日: 2020-11-11, 最終更新日: 2023-11-22)
主引用文献Kamata, S.,Oyama, T.,Saito, K.,Honda, A.,Yamamoto, Y.,Suda, K.,Ishikawa, R.,Itoh, T.,Watanabe, Y.,Shibata, T.,Uchida, K.,Suematsu, M.,Ishii, I.
PPAR alpha Ligand-Binding Domain Structures with Endogenous Fatty Acids and Fibrates.
Iscience, 23:101727-101727, 2020
Cited by
PubMed Abstract: Most triacylglycerol-lowering fibrates have been developed in the 1960s-1980s before their molecular target, peroxisome proliferator-activated receptor alpha (PPARα), was identified. Twenty-one ligand-bound PPARα structures have been deposited in the Protein Data Bank since 2001; however, binding modes of fibrates and physiological ligands remain unknown. Here we show thirty-four X-ray crystallographic structures of the PPARα ligand-binding domain, which are composed of a "Center" and four "Arm" regions, in complexes with five endogenous fatty acids, six fibrates in clinical use, and six synthetic PPARα agonists. High-resolution structural analyses, in combination with coactivator recruitment and thermostability assays, demonstrate that stearic and palmitic acids are presumably physiological ligands; coordination to Arm III is important for high PPARα potency/selectivity of pemafibrate and GW7647; and agonistic activities of four fibrates are enhanced by the partial agonist GW9662. These results renew our understanding of PPARα ligand recognition and contribute to the molecular design of next-generation PPAR-targeted drugs.
PubMed: 33205029
DOI: 10.1016/j.isci.2020.101727
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.735 Å)
構造検証レポート
Validation report summary of 6kay
検証レポート(詳細版)ダウンロードをダウンロード

227111

件を2024-11-06に公開中

PDB statisticsPDBj update infoContact PDBjnumon